SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...

SpringWorks Therapeutics (SWTX) saw the biggest retail follower increase among biotech stocks last week on Stocktwits, even ...

根据监管文件显示，SpringWorks Therapeutics, Inc.（NASDAQ:SWTX）首席运营官Edris Badreddin于2025年3月3日出售了大量公司普通股。Badreddin以每股53.12美元至56.20美元的价格出售了20,000股，交易总额约为1,084,592美元。在SWTX过去六个月股价上涨26%且保持93%高毛利率的强劲势头下完成了此次交易。根据 ...

根据提交给美国证券交易委员会的文件显示，SpringWorks Therapeutics, Inc. (NASDAQ: SWTX )的首席执行官Islam Saqib最近进行了一系列股票交易。3月3日，Saqib通过多笔交易共计出售了48,000股公司普通股。这些股票的售价在每股52.97美元至56.89美元之间，总价值约266万美元。根据 InvestingPro ...

智通财经APP获悉，当地时间2月11日，SpringWorks Therapeutics 宣布，美国 FDA 已批准其 MEK 抑制剂 Gomekli（mirdametinib）上市，用于治疗患有 1 型神经纤维瘤病 ...

Barclays analyst Peter Lawson says SpringWorks Therapeutics (SWTX) this morning cancelled from the firm’s conference next week, following ...

据路透2月10日消息，知情人士称，默克正深入洽谈收购美国癌症与罕见病制药商SpringWorks Therapeutics，预计未来几周内签署协议。SpringWorks的市值约为34 ...

We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

Our analysis of options history for SpringWorks Therapeutics SWTX revealed 9 unusual trades. Delving into the details, we ...

While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.

On February 10, 2025, the Group confirmed advanced discussions about a potential acquisition of SpringWorks Therapeutics ( SWTX ), Inc., USA. At the time of the preparation of the Consolidated ...

SpringWorks Therapeutics sprung out of Pfizer’s storeroom, when a rare disease advocacy group pushed to keep a program for neurofibromatosis alive. This method could work for “every rare disease under ...